CytomX Therapeutics, Inc. (6C1.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:00AM CEST. Market open.
| Previous close | 1.6910 |
| Open | 1.7120 |
| Bid | 1.7070 x 200000 |
| Ask | 1.7540 x 200000 |
| Day's range | 1.7120 - 1.7120 |
| 52-week range | 0.9760 - 4.4020 |
| Volume | |
| Avg. volume | 704 |
| Market cap | 136.631M |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | 9.01 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript May 8, 2024 CytomX Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.1669, expectations were $-0.03. CytomX Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
- Thomson Reuters StreetEvents
Q1 2024 CytomX Therapeutics Inc Earnings Call
Q1 2024 CytomX Therapeutics Inc Earnings Call
- GuruFocus.com
CytomX Therapeutics Inc (CTMX) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Explore key financial outcomes and clinical advancements as CytomX Therapeutics Inc (CTMX) navigates through Q1 2024 with robust partnerships and innovative cancer treatments.
© 2024 Yahoo. All rights reserved.